Claire Comerford
Research Subjects
Claire Comerford has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
J. Quinn
RCSI Beaumont Cancer Centre Dublin Ireland
2 shared publications- Jamie M. O'SUllivan
Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland
2 shared publications A. Beausang
Histopathology Department, Beaumont Hospital, Dublin, Ireland
1 shared publicationAnnmarie Ryan‐Hall
Haemophilia Comprehensive Care Centre Cork University Hospital Cork Ireland
1 shared publication- Brenton Cavanagh
Cellular and Molecular Imaging Core, RCSI University of Medicine and Health Sciences, Dublin, Ireland
1 shared publication Brid Booth‐Fleming
Haemophilia Comprehensive Care Centre Cork University Hospital Cork Ireland
1 shared publication
Latest Publications
- 15 August 2023
- Published by Wiley in British Journal of Haematology
- Vol. 203 (3) , 351-352
Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants
Venous thromboembolism (VTE) continues to cause significant morbidity and excess mortality in patients with multiple myeloma. The report by Costa and colleagues demonstrates superiority of direct oral anticoagulants over aspirin in terms of VTE prevention, without increased bleeding complications seen.Commentary on: Costa et al. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta‐analysis. Br J Haematol 2023;203:395–403.
- 15 August 2023
- Published by Wiley in British Journal of Haematology
- Vol. 203 (3) , 351-352
Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants
Venous thromboembolism (VTE) continues to cause significant morbidity and excess mortality in patients with multiple myeloma. The report by Costa and colleagues demonstrates superiority of direct oral anticoagulants over aspirin in terms of VTE prevention, without increased bleeding complications seen.Commentary on: Costa et al. Direct oral anticoagulants versus aspirin for primary thromboprophylaxis in patients with multiple myeloma undergoing outpatient therapy: A systematic review and updated meta‐analysis. Br J Haematol 2023;203:395–403.
- Open Access
- 10 July 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (10) , 2350-2365
Breast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
- 10 July 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (10) , 2350-2365
Open AccessBreast cancer cells mediate endothelial cell activation, promoting von Willebrand factor release, tumor adhesion, and transendothelial migration
- Open Access
- 23 June 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (8) , 1766-1777
The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies
- 23 June 2022
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 20 (8) , 1766-1777
Open AccessThe role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies
- 20 November 2020
- Published by Wiley in Haemophilia
- Vol. 27 (4) , E484-E486
Inhibitor development in an elderly patient with severe factor IX deficiency being treated with ALPROLIX, a recombinant factor IX Fc fusion protein
- 20 November 2020
- Published by Wiley in Haemophilia
- Vol. 27 (4) , E484-E486
Inhibitor development in an elderly patient with severe factor IX deficiency being treated with ALPROLIX, a recombinant factor IX Fc fusion protein
- 18 October 2017
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 187 (2) , 349-350
Pituitary plasmacytoma—a rare presentation of multiple myeloma
- 18 October 2017
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 187 (2) , 349-350
Pituitary plasmacytoma—a rare presentation of multiple myeloma